Role of MCT8 in pregnant ladies
Not Applicable
- Registration Number
- CTRI/2021/10/037593
- Lead Sponsor
- Indian Council of Medical Research ICMR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Pregnant ladies first, second, third trimester of age group 18-38 years
Exclusion Criteria
Chronic hypertension, overt diabetes, IVF pregnancy, multifetal gestation, thyroid cancer/ thyroidectomy/ any surgery of thyroid
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To measure the MCT 8 expression in placenta of patients with a known adverse pregnancy outcome after delivery and to compare with various clinical factorsTimepoint: 2 years
- Secondary Outcome Measures
Name Time Method To evaluate the impact of MCT 8 expression across different adverse pregnancy outcomes and its relation to maternal thyroid hormone status.Timepoint: 3 years